OpenURL Connection Search

Select item for more details and to access through your institution.

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CART-cell therapy.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1419788
By:
- Ladbury, Colton;
- Claire Hao;
- Watkins, William Tyler;
- Sampath, Sagus;
- Jeffrey Wong;
- Amini, Arya;
- Sokolov, Karen;
- Jekwon Yeh;
- Al Feghali, Karine A.;
- Dorine de Jong;
- Maniyedath, Arjun;
- Shirvani, Shervin;
- Nikolaenko, Liana;
- Matthew Mei;
- Herrera, Alex;
- Popplewell, Leslie;
- Budde, Lihua Elizabeth;
- Dandapani, Savita
Publication type:
Article
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma.
Published in:
Cancers, 2023, v. 15, n. 6, p. 1747, doi. 10.3390/cancers15061747
By:
- Ladbury, Colton;
- Dandapani, Savita;
- Hao, Claire;
- Fabros, Mildred;
- Amini, Arya;
- Sampath, Sagus;
- Glaser, Scott;
- Sokolov, Karen;
- Yeh, Jekwon;
- Baird, John H.;
- Kambhampati, Swetha;
- Herrera, Alex;
- Mei, Matthew;
- Nikolaenko, Liana;
- Shouse, Geoffrey;
- Budde, Lihua E.
Publication type:
Article
Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1419788
By:
- Ladbury, Colton;
- Hao, Claire;
- Watkins, William Tyler;
- Sampath, Sagus;
- Wong, Jeffrey;
- Amini, Arya;
- Sokolov, Karen;
- Jekwon Yeh;
- Al Feghali, Karine A.;
- de Jong, Dorine;
- Maniyedath, Arjun;
- Shirvani, Shervin;
- Nikolaenko, Liana;
- Mei, Matthew;
- Herrera, Alex;
- Popplewell, Leslie;
- Budde, Lihua Elizabeth;
- Dandapani, Savita
Publication type:
Article

Found: 3

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CART-cell therapy.

Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma.

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy.